Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

Galera Therapeutics, Inc., a clinical-stage drug discovery company, whose research and development is based in St. Louis, has announced that it has secured $150...

St. Louis Has “Agglomeration” In AgTech, According To A Brookings Report, And That’s A...

The Brookings Institution, a nonprofit public policy think tank based in Washington, DC released a report on July 25 (2018) entitled “Rethinking Cluster Initiatives”...

GlobalSTL Attracts International Healthcare Innovators by Focusing in on St. Louis Strengths

Thirteen Israeli and Irish companies are working to launch business deals with St. Louis healthcare systems and corporations following the inaugural GlobalSTL Health Innovation Summit.
NRGene

NRGene Is Racing Against Time to Solve Hunger

After moving to St. Louis several months ago, the St. Louis Mosaic Project helped founders settle in St. Louis and build connections."We need to...
Dollar sign fundraising

12 Fundraising Tips for BioTech companies from Cultivation Capital’s Life Sciences Fund

Bill Schmidt, Managing Partner of Cultivation Capital's Life Science Fund, shares tips for BioTech companies focused on fundraising.

Cortex-based Affigen Announces $17 million Series A Led by Black Beret Life Sciences

Affigen, a biotechnology company based in the Cortex Innovation Community that develops therapeutics targeting cell lineage-specific tumor proteins, today announced the closing of a $17...

That’s Life (Sciences)

We examine St. Louis’ life sciences startup scene: a hotbed of innovation, growth and promise.
Bio STL Global STL EQ

International Affair

How BioSTL’s team is building a relationship with Israel’s startups to grow St. Louis’ ecosystem.

Latest Stories

Popular Stories